A new website has just been launched to provide assistance to young patients wishing to learn about their reproductive options in the midst of a cancer diagnosis. Now patients and their clinicians can go to the new Patient Navigator for Fertility Preservation website, which includes…
Last June, we discussed the launch of a new online dictionary dedicated to defining reproductive words in easy to understand terms. Since then, we’ve been linking our reproductive terms to the website, Repropedia.org, which is an authoritative website that provides short, jargon-free descriptions to the…
I recently had a conversation with Jill de Bartok, the program manager for patient services at the National Brain Tumor Society (NBTS), about their ever-growing programs. NBTS funds cutting-edge science and serves as a resource for researchers and medical professionals. It also provides services for…
An article submitted in early March to the Emax Health Web site quotes the NEJM article by Dr. Jeruss and Teresa Woodruff. It also describes Oncofertility, explaining what it is. Furthermore, the author directs people to the MyOncofertility Web site, an effort led by the…
Pediatric and Adolescent Committee and Basic Science Committee Ovarian Tissue Resources The advent of ovarian tissue cryopreservation has allowed an unprecedented view of young pediatric ovaries. Now that this procedure is no longer considered experimental it is performed at many sites throughout the United States.…
2023 ONCOFERTILITY CONSORTIUM CONFERENCE BOOKLET Over 220 attendees from all 6 continents around the globe participated in the 15th Annual Conference of Oncofertility Consortium Novemver 6-8, 2023, hosted by the Magee-Women’s Research Institute & Foundation in Pittsburgh, PA, USA. Last year marked the second time the…
We welcome you to the 15th Annual Conference of the Oncofertility Consortium, November 6-8, 2023, that will be hosted again by the Magee-Womens Research Institute & Foundation at The Westin Pittsburgh, PA, USA. For registration, agenda, hotel reservation, abstract submission, sponsorship opportunities & FAQs, please visit the official website…
Thinking through your fertility options now will help you create the family you want later. Whether you’re a cancer patient, partner, or parent of a cancer patient, Take Charge Initiative can help. Please visit the initiative website to get all the information you need: https://mycancerfertility.org/
The Oncofertility Consortium congratulates our founder Prof. Teresa K. Woodruff, Ph.D. for being named Interim President of Michigan State University (MSU). Currently, Dr. Woodruff is also a Foundation Professor in both the Department of Obstetrics, Gynecology, and Reproductive Biology and the Department of Biomedical Engineering at MSU’s College of…
Over 240 attendees from 15 countries around the globe participated in the 14th Annual Conference of Oncofertility Consortium May 2-4, 2022, that was in-person and hosted by the Magee-Women’s Research Institute & Foundation in Pittsburgh, PA, USA. This 3-day meeting was the first opportunity for…
Oncofertility National Science Education Network (ONSEN) Dr. Teresa Woodruff initiated the Oncofertility National Science Education Network (ONSEN) in an effort to help attract, prepare and retain female high school students in science majors and careers. ONSEN features educational programs in oncofertility that have been developed…
Introdução Muitos homens que foram diagnosticados com uma doença oncológica consideram a preservação da fertilidade importante e gostariam de ter mais informação sobre as técnicas existentes. No entanto, podem – Não se sentir confortáveis para abordarem aspetos relacionados com a fertilidade. – Não ter consciência…
Introdução Muitos homens que foram diagnosticados com uma doença oncológica consideram a preservação da fertilidade importante e gostariam de ter mais informação sobre as técnicas existentes. No entanto, podem – Não se sentir confortáveis para abordarem aspetos relacionados com a fertilidade. – Não ter consciência…
Introdução Muitas mulheres que foram diagnosticadas com uma doença oncológica consideram a preservação da fertilidade importante e gostariam de ter mais informação sobre as técnicas existentes. No entanto, podem – Não se sentir confortáveis para abordarem aspetos relacionados com a fertilidade. – Não ter consciência…
Research and Translational Medicine: Meeting the Needs of Cancer Patients and Survivors November 14-16, 2017 Prentice Women’s Hospital 250 E. Superior St., Third Floor Chicago, IL 60611 Tuesday, November 14, 2017 Day 1 Education Sessions Registration and Continental Breakfast (8:30 – 9:00am) Fellow Education (9:00am –…
The 15th Annual Conference of the Oncofertility Consortium, November 6-8, 2023, will be hosted again by Magee-Womens Research Institute & Foundation, in Pittsburgh, PA, USA. The Annual Conference provides an accessible platform for international oncofertility leaders and those new to the field to share their perspectives, discoveries, and vision…
Founder of Oncofertility Consortium: Teresa K. Woodruff, PhD Director of Oncofertility Consortium: Mahmoud Salama MD, PhD Chairs of Scientific Committees of Oncofertility Consortium: Children & Adolescents Oncofertility (Pediatric Initiative Network; PIN): Lillian R. Meacham, MD Female Oncofertility: Leslie Appiah, MD Male Oncofertility: Kyle Orwig,
As the field of oncofertility continues to advance, the Oncofertility Consortium seeks to support various high-risk, high-gain initiatives in order to facilitate the launch of early-stage ideas into future grant-funded projects. Applications for pilot projects are evaluated each year, with only a few awarded with…
Considerations should also be made for young women who are pregnant at the time of cancer diagnosis to achieve a healthy pregnancy. By 2002, the incidence of pregnancy-associated breast cancer had increased to 37.4 per 100,000 deliveries, up from 16.0 in 19631. The co-existence of…
What do patients want to know? Fertility is of great importance to many people diagnosed with cancer 76% of childless reproductive-aged cancer survivors state that they would like to have children in the future1. Many men report that sperm cryopreservation prior to chemotherapy helped them…
Who are appropriate candidates? Ovarian tissue cryopreservation is usually only considered in certain cases: Patients who do not have time to undergo controlled ovarian stimulation (COS) for embryo or oocyte cryopreservation. COS is the more mature technology and should be the first-line treatment if time allows. Patients…
In general, for women with cancer, controlled ovarian stimulation (COS) for embryo or oocyte cryopreservation is similar to IVF for infertile couples. However, there are some additonal considerations in this population: What is the general protocol for COS? Pre-cycle considerations Ovarian reserve testing. A study…